OtherBASIC SCIENCE INVESTIGATIONS
Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
Vladimir Tolmachev, Mikaela Friedman, Mattias Sandström, Tove L.J. Eriksson, Daniel Rosik, Monika Hodik, Stefan Ståhl, Fredrik Y. Frejd and Anna Orlova
Journal of Nuclear Medicine February 2009, 50 (2) 274-283; DOI: https://doi.org/10.2967/jnumed.108.055525
Vladimir Tolmachev
Mikaela Friedman
Mattias Sandström
Tove L.J. Eriksson
Daniel Rosik
Monika Hodik
Stefan Ståhl
Fredrik Y. Frejd
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 50, Issue 2
February 2009
Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
Vladimir Tolmachev, Mikaela Friedman, Mattias Sandström, Tove L.J. Eriksson, Daniel Rosik, Monika Hodik, Stefan Ståhl, Fredrik Y. Frejd, Anna Orlova
Journal of Nuclear Medicine Feb 2009, 50 (2) 274-283; DOI: 10.2967/jnumed.108.055525
Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
Vladimir Tolmachev, Mikaela Friedman, Mattias Sandström, Tove L.J. Eriksson, Daniel Rosik, Monika Hodik, Stefan Ståhl, Fredrik Y. Frejd, Anna Orlova
Journal of Nuclear Medicine Feb 2009, 50 (2) 274-283; DOI: 10.2967/jnumed.108.055525
Jump to section
Related Articles
Cited By...
- PET of EGFR Expression with an 18F-Labeled Affibody Molecule
- HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
- A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
- Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer
- Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression